Reprogramming of human somatic cells to pluripotency with defined factors View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2007-12-23

AUTHORS

In-Hyun Park, Rui Zhao, Jason A. West, Akiko Yabuuchi, Hongguang Huo, Tan A. Ince, Paul H. Lerou, M. William Lensch, George Q. Daley

ABSTRACT

Pluripotency pertains to the cells of early embryos that can generate all of the tissues in the organism. Embryonic stem cells are embryo-derived cell lines that retain pluripotency and represent invaluable tools for research into the mechanisms of tissue formation. Recently, murine fibroblasts have been reprogrammed directly to pluripotency by ectopic expression of four transcription factors (Oct4, Sox2, Klf4 and Myc) to yield induced pluripotent stem (iPS) cells. Using these same factors, we have derived iPS cells from fetal, neonatal and adult human primary cells, including dermal fibroblasts isolated from a skin biopsy of a healthy research subject. Human iPS cells resemble embryonic stem cells in morphology and gene expression and in the capacity to form teratomas in immune-deficient mice. These data demonstrate that defined factors can reprogramme human cells to pluripotency, and establish a method whereby patient-specific cells might be established in culture. More... »

PAGES

141-146

Journal

TITLE

Nature

ISSUE

7175

VOLUME

451

Related Patents

  • Methods For Tissue Generation
  • Method For Reprogramming Cells
  • Modified Polynucleotides For The Production Of Secreted Proteins
  • Reprogramming Of Somatic Cells
  • Assay For Mutations In Stem Cells And Their Derivatives
  • Modified Polynucleotides For The Production Of Biologics And Proteins Associated With Human Disease
  • Pluripotent Cell Lines And Methods Of Use Thereof
  • New Serum-Free Medium For Inducing Pluripotent Stem Cells Quickly With High Efficiency And Method Using Thereof
  • Method To Direct Differentiation Of Pluripotent Stem Cells Into Functional Heart Muscle
  • A Non-Viral System For The Generation Of Induced Pluripotent Stem (Ips) Cells
  • Nuclear Reprogramming Factor Comprising Mirna And A Protein Factor
  • Cell Culture Platform For Single Cell Sorting And Enhanced Reprogramming Of Ipscs
  • Reprogramming Of Somatic Cells
  • Modifying The Specificity Of Non-Coding Rna Molecules For Silencing Genes In Eukaryotic Cells
  • Compositions And Methods For Generation Of Human Epithelial Stem Cells
  • Isolated Mammalian Somatic Cells Containing Modified Rna Encoding Oct4, Sox2, And Klf4
  • Detection Of Human Somatic Cell Reprogramming
  • Use Of Cellular Extracts For Obtaining Pluripotent Stem Cells
  • Protein-Induced Pluripotent Cell Technology And Uses Thereof
  • Method For Production Of Reprogrammed Cell Using Chromosomally Unintegrated Virus Vector
  • Somatic Cell Reprogramming
  • Modified Polynucleotides Encoding Granulysin
  • Method For Producing Stem Cell Clones Suitable For Induction Of Differentiation Into Somatic Cells
  • Induced Pluripotent Stem Cells Produced With Oct3/4, Klf4 And Sox2
  • Method For Production Of Reprogrammed Cell Using Chromosomally Unintegrated Virus Vector
  • Methods For Producing Hormone Secreting Cells In A Subject
  • Induced Pluripotent Stem Cells With Synthetic Modified Rnas
  • Methods Of Promoting Lymphangiogenesis
  • Kit For Making Induced Pluripotent Stem Cells Using Modified Rnas
  • Generation Of Induced Pluripotent Stem Cells From Cord Blood
  • Pluripotent Cell Lines And Methods Of Use Thereof
  • Method For Modulating Myelination
  • Methods For Expanding And Maintaining Human Pluripotent Stem Cells (Pscs) In An Undifferentiated State In A Single Cell Suspension Culture
  • Engineered Nucleic Acids Encoding A Modified Erythropoietin And Their Expression
  • Method For Producing Engineered Heart Muscle (Ehm)
  • Modified Polynucleotides For Treating Galactosylceramidase Protein Deficiency
  • Methods For Producing Enucleated Erythroid Cells Derived From Pluripotent Stem Cells
  • Large Scale Production Of Retinal Pigment Epithelial Cells
  • Cardiosphere-Derived Cells And Exosomes Secreted By Such Cells In The Treatment Of Heart Failure With Preserved Ejection Fraction
  • Early Developmental Genomic Assay For Characterizing Pluripotent Stem Cell Utility And Safety
  • Downregulation Of Mir-7 For Promotion Of Beta Cell Differentiation And Insulin Production
  • Exosomes And Micro-Ribonucleic Acids For Tissue Regeneration
  • Composition For Inducing Pluripotent Stem Cell, And Use Thereof
  • Methods And Products For Dedifferentiation Of Cells
  • Cell Compositions Derived From Dedifferentiated Reprogrammed Cells
  • A Protein-Induced Pluripotent Cell Technology Uses Thereof
  • Modulators Of Telomere Disease
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Methods Of Generating Lineage-Specific Cells From Undifferentiated Human Pluripotent Stem Cells Cultured In A Single Cell Suspension Culture
  • Modified Polynucleotides Encoding Apoptosis Inducing Factor 1
  • Methods Of Generating Corneal Cells And Cell Populations Comprising Same
  • Methods And Platforms For Drug Discovery Using Induced Pluripotent Stem Cells
  • Delivery And Formulation Of Engineered Nucleic Acids
  • Methods And Compositions For Maintaining Genomic Stability In Cultured Stem Cells
  • Method For Preparing Induced Paraxial Mesoderm Progenitor (Ipam) Cells And Their Use
  • Differentiation Into Brown Adipocytes
  • Novel Methods And Culture Media For Culturing Pluripotent Stem Cells
  • Ets2 And Mesp1 Generate Cardiac Progenitors From Fibroblasts
  • Method For Preparing Induced Paraxial Mesoderm Progenitor (Ipam) Cells And Their Use
  • Use Of Cellular Extracts For Obtaining Pluripotent Stem Cells
  • Induction Of Pluripotent Cells
  • Modified Polynucleotides For Treating Protein Deficiency
  • Detection Of Human Somatic Cell Reprogramming
  • Mathematical Image Analysis Based Cell Reprogramming With Applications For Epigenetic And Non-Epigenetic Base Induced Pluripotent Stem Cell Derivation
  • Method For Improving Efficiency Of Inducing Pluripotent Stem Cell
  • Somatic Cell Reprogramming By Retroviral Vectors Encoding Oct3/4. Klf4, C-Myc And Sox2
  • Methods For Production Of Platelets From Pluripotent Stem Cells And Compositions Thereof
  • Kits Comprising Linear Dnas For Sustained Polypeptide Expression Using Synthetic, Modified Rnas
  • Somatic Cell Reprogramming
  • Preparation Of Photoreceptors For The Treatment Of Retinal Diseases
  • Efficient Method For Nuclear Reprogramming
  • Reprogramming A Cell By Inducing A Pluripotent Gene Through Rna Interference
  • Compositions, Kits, And Methods For Making Induced Pluripotent Stem Cells Using Synthetic Modified Rnas
  • Induction Of Pluripotent Cells
  • Modified Polynucleotides Encoding Septin-4
  • Modified Polynucleotides Encoding Cited4
  • Combinational Use Of Mechanical Manipulation And Programin Derivatives To Increase Oct4, Sox2, Nanog Or C-Myc Expression In Fibroblasts
  • Isolated Mesenchymal Progenitor Cells And Extracellular Matrix Produced Thereby
  • Generation Of Neural Stem Cells And Motor Neurons
  • Induced Pluripotent Stem Cell Model Of Chronic Myeloid Leukemia Revealed Olfactomedin 4 As A Novel Therapeutic Target In Leukemia Stem Cells
  • Media For Culturing Pluripotent Stem Cells
  • Preparation Of Retinal Pigment Epithelium Cells
  • Modified Polynucleotides For The Production Of Nuclear Proteins
  • Method Of Efficiently Establishing Induced Pluripotent Stem Cells
  • Human Pluripotent Stem Cells Induced From Undifferentiated Stem Cells Derived From A Human Postnatal Tissue
  • Populations Of Neural Progenitor Cells And Methods Of Producing And Using Same
  • Single Cells Pluripotent Stem Cells In A Suspension Culture
  • Large Scale Production Of Retinal Pigment Epithelial Cells
  • Retinal Pigment Epithelium Cell Compositions
  • Systems And Methods For Increasing Efficiency Of Genome Editing
  • Assembly Of Functionally Integrated Human Forebrain Spheroids And Methods Of Use Thereof
  • Methods And Products For Dedifferentiation Of Cells
  • Reprogrammation Of Eukaryotic Cells With Engineered Microvesicles
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Generation Of Reprogrammed Pluripotent Cells
  • Formulation For Regeneration Of Bone, Cartilage, Teeth, And Periodontium And Treatment Of Tumors And Cysts
  • Culture Media For Pluripotent Stem Cells
  • Populations Of Hematopoietic Progenitors And Methods Of Enriching Stem Cells Therefor
  • Introducing Silencing Activity To Dysfunctional Rna Molecules And Modifying Their Specificity Against A Gene Of Interest
  • Combinational Use Of Mechanical Manipulation And Programin Derivatives To Increase Oct4, Sox2, Or Nanog Expression In Fibroblasts
  • Polycistronic Vector For Human Induced Pluripotent Stem Cell Production
  • Fingerprint For Cell Identity And Pluripotency
  • Modified Polynucleotides For The Production Of Proteins
  • Reprogramming Of Somatic Cells With Purified Proteins
  • Reprogramming T Cells And Hematopoietic Cells
  • Method For Production Of Pluripotent Stem Cell
  • Bioartifical Lung
  • Differentiated Cells Originating In Artificial Pluripotent Stem Cells
  • Methods For Telomere Length And Genomic Dna Quality Control Analysis In Pluripotent Stem Cells
  • Human Airway Stem Cells In Lung Epithelial Engineering
  • Modified Polynucleotides Encoding Basic Helix-Loop-Helix Family Member E41
  • Human Blood-Brain Endothelial Cells Derived From Pluripotent Stem Cells And Blood-Brain Barrier Model Thereof
  • Genetically Modified Stem Cells
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Production Of Reprogrammed Pluripotent Cells
  • Stem Cell Culture Medium And Method
  • Method For Inducing Cells To Less Mature State
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Method For Preparing Induced Pluripotent Stem Cells And Culture Medium Used For Preparing Induced Pluripotent Stem Cells
  • Modified Polynucleotides Encoding Copper Metabolism (Murr1) Domain Containing 1
  • Protein-Induced Pluripotent Cell Technology And Uses Thereof
  • Methods For Measuring Therapeutic Effects Of Retinal Disease Therapies
  • Combinational Use Of Mechanical Manipulation And Programin Derivatives To Increase Oct4, Sox2, Or Nanog Expression In Fibroblasts
  • Generation Of Neural Stem Cells
  • Cdc-Derived Exosomes For Treatment Of Ventricular Tachyarrythmias
  • In Vitro Differentiation Of Pluripotent Stem Cells To Pancreatic Endoderm Cells (Pec) And Endocrine Cells
  • Sustained Polypeptide Expression From Synthetic, Modified Rnas And Uses Thereof
  • Polynucleotides Encoding Immune Modulating Polypeptides
  • Hemangio Colony Forming Cells And Non-Engrafting Hemangio Cells
  • Modified Polynucleotides For The Production Of Proteins Associated With Human Disease
  • Methods For The Production Of Ips Cells Using Epstein-Barr (Ebv)-Based Reprogramming Vectors
  • Formulation And Delivery Of Plga Microspheres
  • Culture Method Of Embryoid Bodies And/Or Neural Stem Cells Derived From Human Differentiated Cell-Derived Pluripotent Stem Cells
  • Stem Cells And Uses Thereof
  • Methods And Formulations For Orthopedic Cell Therapy
  • Early Developmental Genomic Assay For Characterizing Pluripotent Stem Cell Utility And Safety
  • Optimized Methods For Generation Of Cardiac Stem Cells From Cardiac Tissue And Their Use In Cardiac Therapy
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Delivery And Formulation Of Engineered Nucleic Acids
  • Method For Production Of Pluripotent Stem Cell
  • Maintenance Of Genomic Stability In Cultured Stem Cells
  • Stem Cell Culture Medium And Method
  • Ets2 And Mesp1 Generate Cardiac Progenitors From Fibroblasts
  • Compositions And Methods Of Altering Cholesterol Levels
  • Generation Of Induced Pluripotent Stem (Ips) Cells
  • Polynucleotides Encoding Low Density Lipoprotein Receptor
  • A Method To Direct Differentiation Of Pluripotent Stem Cells Into Functional Heart Muscle
  • Materials And Methods For Generating Pluripotent Stem Cells
  • Detection Of Human Somatic Cell Reprogramming
  • Populations Of Pancreatic Progenitor Cells And Methods Of Isolating And Using Same
  • Nuclear Reprogramming Factor
  • Induced Presomitic Mesoderm (Ipsm) Cells And Their Use
  • Functional Genomics Assay For Characterizing Pluripotent Stem Cell Utility And Safety
  • Cannabidiol-Containing Compositions And Uses Thereof
  • Modified Polynucleotides For The Production Of G-Csf
  • Modified Polynucleotides Encoding Siah E3 Ubiquitin Protein Ligase 1
  • Methods, Systems And Compositions Relating To Cell Conversion Via Protein-Induced In-Vivo Cell Reprogramming
  • Culture Method Of Embryoid Bodies And/Or Neural Stem Cells Derived From Human Differentiated Cell-Derived Pluripotent Stem Cells
  • Culture Method Of Embryoid Bodies And/Or Neural Stem Cells Derived From Human Differentiated Cell-Derived Pluripotent Stem Cells
  • Modified Polynucleotides For The Production Of Secreted Proteins
  • Preparation Of Retinal Pigment Epithelium Cells
  • Method For Preparing Induced Paraxial Mesoderm Progenitor (Ipam) Cells And Their Use
  • Reprogramming Somatic Cells Using Retroviral Vectors Comprising Oct-4 And Sox2 Genes
  • Terminally Modified Rna
  • Stem Cells And Uses Thereof
  • Method For Producing Induced Pluripotent Stem Cells, Cardiomyocytes Or Precursor Cells Thereof
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Programming And Reprogramming Of Cells
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Dlin-Kc2-Dma Lipid Nanoparticle Delivery Of Modified Polynucleotides
  • Low-Molecular-Compound For Improving Production, Maintenance And Proliferation Of Pluripotent Stem Cells, Composition Comprising The Same, And Culture Method
  • In Vivo Production Of Proteins
  • Pluripotent Stem Cell-Derived 3d Retinal Tissue And Uses Thereof
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Hemangio-Colony Forming Cells
  • Isolated Naive Pluripotent Stem Cells And Methods Of Generating Same
  • Methods For The Production Of Ips Cells
  • In Vitro Model Of Spinal Muscular Atrophy
  • Preparation Of Photoreceptors For The Treatment Of Retinal Diseases
  • Insulin Producing Cells Derived From Pluripotent Stem Cells
  • Pericyte Progenitor Cells And Methods Of Generating And Using Same
  • Methods For Maturing Cardiomyocytes And Uses Thereof
  • Modified Polynucleotides Encoding Hepatitis A Virus Cellular Receptor 2
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Myc Variants Improve Induced Pluripotent Stem Cell Generation Efficiency
  • Cardiosphere-Derived Cells And Exosomes Secreted By Such Cells In The Treatment Of Muscular Dystrophy
  • Generation Of Induced Pluripotent Stem (Ips) Cells
  • Modified Polynucleotides For The Production Of Oncology-Related Proteins And Peptides
  • Compositions For Mesoderm Derived Isl1+ Multipotent Cells (Imps), Epicardial Progenitor Cells (Epcs) And Multipotent C56c Cells (C56cs) And Methods Of Producing And Using Same
  • Modified Polynucleotides For The Production Of Cosmetic Proteins And Peptides
  • Providing Ipscs To A Customer
  • Methods For The Production Of Ips Cells Using Non-Viral Approach
  • Human Pluripotent Stem Cells Induced From Undifferentiated Stem Cells Derived From A Human Postnatal Tissue
  • Method For Rejuvenating Cells
  • Multipotent Stem Cell Cultures
  • Modulators Of Telomere Disease
  • Compositions And Methods For Restoring Or Preventing Loss Of Vision Caused By Disease Or Traumatic Injury
  • Modified Polynucleotides For The Production Of Proteins Associated With Blood And Lymphatic Disorders
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Method To Reduce Oncogenic Potential Of Induced Pluripotent Stem Cells From Aged Donors
  • Low-Molecular-Compound For Improving Production, Maintenance And Proliferation Of Pluripotent Stem Cells, Composition Comprising The Same, And Culture Method
  • Method For Producing A Protein Of Interest In A Primate
  • Cell Compositions Derived From Dedifferentiated Reprogrammed Cells
  • Method For Inducing Pluripotency In Human Somatic Cells With Prdm14 Or Nfrkb
  • Differentially Methylated Regions Of Reprogrammed Induced Pluripotent Stem Cells, Method And Compositions Thereof
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Split Dose Administration
  • Reprogramming Methods And Cell Culture Platforms
  • Modified Polynucleotides For The Production Of Proteins
  • Reprogrammation Of Eukaryotic Cells With Engineered Microvesicles
  • Modified Polynucleotides
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Method Of Efficiently Establishing Induced Pluripotent Stem Cells
  • Human Pluripotent Stem Cells Induced From Undifferentiated Stem Cells Derived From A Human Postnatal Tissue
  • Populations Of Hematopoietic Progenitors And Methods Of Enriching Stem Cells Therefor
  • Formulation And Delivery Of Plga Microspheres
  • Methods For Making And Using Sinoatrial Node-Like Pacemaker Cardiomyocytes And Ventricular-Like Cardiomyocytes
  • Transcription Factor Mediated Programming Towards Megakaryocytes
  • Non-Human Mammal Model Of Human Degenerative Disorder, Uses Thereof, And Method Of Treating Human Degenerative Disorder
  • Method For Preparing Induced Paraxial Mesoderm Progenitor (Ipam) Cells And Their Use
  • Functional Astrocytes And Cortical Neurons From Induced Pluripotent Stem Cells And Methods Of Use Thereof
  • Compositions And Methods For Restoring Or Preventing Loss Of Vision Caused By Disease Or Traumatic Injury
  • Modified Polynucleotides Encoding Aquaporin-5
  • Protein-Induced Pluripotent Cell Technology And Uses Thereof
  • Epigenomic Induced Pluripotent Stem Cell Signatures
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Autologous Mammalian Models Derived From Induced Pluripotent Stem Cells And Related Methods
  • Oct3/4, Klf4, C-Myc And Sox2 Produce Induced Pluripotent Stem Cells
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Modified Polynucleotides Encoding Aryl Hydrocarbon Receptor Nuclear Translocator
  • Modified Polynucleotides For The Production Of Proteins Associated With Blood And Lymphatic Disorders
  • Method Of Effecting De-Differentiation Of A Cell
  • Methods, Systems And Compositions Relating To Cell Conversion Via Protein-Induced In-Vivo Cell Reprogramming
  • Human Pluripotent Stem Cells Induced From Undifferentiated Stem Cells Derived From A Human Postnatal Tissue
  • Method To Reduce Oncogenic Potential Of Induced Pluripotent Stem Cells From Aged Donors
  • Methods And Pharmaceutical Compositions For Expressing A Polynucleotide Of Interest In The Retinal Pigment Epithelium Of A Subject
  • Cell Compositions Derived From Dedifferentiated Reprogrammed Cells
  • Genetically Modified Stem Cells
  • Multipotent Stem Cell Cultures
  • Methods For Differentiating And Purifying Pancreatic Endocrine Cells
  • Large Scale Generation Of Functional Megakaryocytes And Platelets From Human Embryonic Stem Cells Under Stromal-Free Conditions
  • Modified Polynucleotides For The Production Of Proteins Associated With Blood And Lymphatic Disorders
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Modulators Of Telomere Disease
  • Method For Producing Retinal Ganglion Cells From Pluripotent Cells
  • Assembly Of Functionally Integrated Human Forebrain Spheroids And Methods Of Use Thereof
  • Automated System For The Cultivation And Differentiation Of Pluripotent Stem Cells
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nature06534

    DOI

    http://dx.doi.org/10.1038/nature06534

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1011992920

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/18157115


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Genetics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Differentiation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Shape", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cells, Cultured", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Methylation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA-Binding Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Embryonic Stem Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Fetus", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Fibroblasts", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Gene Expression Profiling", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "HMGB Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Homeodomain Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Infant, Newborn", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kruppel-Like Factor 4", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kruppel-Like Transcription Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nanog Homeobox Protein", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Octamer Transcription Factor-3", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pluripotent Stem Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Promoter Regions, Genetic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Proto-Oncogene Proteins c-myc", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "SOXB1 Transcription Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Teratoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transcription Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transplantation, Heterologous", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Division of Pediatric Hematology/Oncology, Children\u2019s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women\u2019s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA", 
                "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Park", 
            "givenName": "In-Hyun", 
            "id": "sg:person.0633264666.40", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633264666.40"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Division of Pediatric Hematology/Oncology, Children\u2019s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women\u2019s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA", 
                "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhao", 
            "givenName": "Rui", 
            "id": "sg:person.0701400066.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701400066.39"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Division of Pediatric Hematology/Oncology, Children\u2019s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women\u2019s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA", 
                "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School"
              ], 
              "type": "Organization"
            }, 
            "familyName": "West", 
            "givenName": "Jason A.", 
            "id": "sg:person.01300040514.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300040514.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Division of Pediatric Hematology/Oncology, Children\u2019s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women\u2019s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA", 
                "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yabuuchi", 
            "givenName": "Akiko", 
            "id": "sg:person.01165236266.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165236266.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Division of Pediatric Hematology/Oncology, Children\u2019s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women\u2019s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA", 
                "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Huo", 
            "givenName": "Hongguang", 
            "id": "sg:person.01206166374.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206166374.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pathology, Brigham and Women\u2019s Hospital, and", 
              "id": "http://www.grid.ac/institutes/grid.62560.37", 
              "name": [
                "Department of Pathology, Brigham and Women\u2019s Hospital, and"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ince", 
            "givenName": "Tan A.", 
            "id": "sg:person.01233401714.29", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233401714.29"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Newborn Medicine, Brigham & Women\u2019s Hospital and Children\u2019s Hospital Boston, Boston, Massachusetts 02115, USA", 
              "id": "http://www.grid.ac/institutes/grid.2515.3", 
              "name": [
                "Division of Newborn Medicine, Brigham & Women\u2019s Hospital and Children\u2019s Hospital Boston, Boston, Massachusetts 02115, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lerou", 
            "givenName": "Paul H.", 
            "id": "sg:person.01071737774.79", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071737774.79"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Division of Pediatric Hematology/Oncology, Children\u2019s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women\u2019s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA", 
                "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lensch", 
            "givenName": "M. William", 
            "id": "sg:person.01022207136.99", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022207136.99"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Division of Pediatric Hematology/Oncology, Children\u2019s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women\u2019s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA", 
                "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Daley", 
            "givenName": "George Q.", 
            "id": "sg:person.01326207001.66", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326207001.66"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nbt1318", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033397919", 
              "https://doi.org/10.1038/nbt1318"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/22780", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021312708", 
              "https://doi.org/10.1038/22780"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt1310", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024578139", 
              "https://doi.org/10.1038/nbt1310"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature05934", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002347899", 
              "https://doi.org/10.1038/nature05934"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature05944", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019109862", 
              "https://doi.org/10.1038/nature05944"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt788", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013128911", 
              "https://doi.org/10.1038/nbt788"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt1335", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049953935", 
              "https://doi.org/10.1038/nbt1335"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt1107-1211a", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003688019", 
              "https://doi.org/10.1038/nbt1107-1211a"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2007-12-23", 
        "datePublishedReg": "2007-12-23", 
        "description": "Pluripotency pertains to the cells of early embryos that can generate all of the tissues in the organism. Embryonic stem cells are embryo-derived cell lines that retain pluripotency and represent invaluable tools for research into the mechanisms of tissue formation. Recently, murine fibroblasts have been reprogrammed directly to pluripotency by ectopic expression of four transcription factors (Oct4, Sox2, Klf4 and Myc) to yield induced pluripotent stem (iPS) cells. Using these same factors, we have derived iPS cells from fetal, neonatal and adult human primary cells, including dermal fibroblasts isolated from a skin biopsy of a healthy research subject. Human iPS cells resemble embryonic stem cells in morphology and gene expression and in the capacity to form teratomas in immune-deficient mice. These data demonstrate that defined factors can reprogramme human cells to pluripotency, and establish a method whereby patient-specific cells might be established in culture.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/nature06534", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "7175", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "451"
          }
        ], 
        "keywords": [
          "embryonic stem cells", 
          "stem cells", 
          "iPS cells", 
          "human somatic cells", 
          "induced pluripotent stem cells", 
          "human iPS cells", 
          "pluripotent stem cells", 
          "human primary cells", 
          "patient-specific cells", 
          "early embryos", 
          "transcription factors", 
          "somatic cells", 
          "ectopic expression", 
          "pluripotency", 
          "gene expression", 
          "human cells", 
          "murine fibroblasts", 
          "defined factors", 
          "primary cells", 
          "cell lines", 
          "dermal fibroblasts", 
          "cells", 
          "invaluable tool", 
          "fibroblasts", 
          "expression", 
          "tissue formation", 
          "immune-deficient mice", 
          "healthy research subjects", 
          "organisms", 
          "embryos", 
          "tissue", 
          "factors", 
          "mechanism", 
          "mice", 
          "same factors", 
          "lines", 
          "culture", 
          "formation", 
          "morphology", 
          "capacity", 
          "tool", 
          "teratoma", 
          "data", 
          "skin biopsies", 
          "research", 
          "method", 
          "biopsy", 
          "research subjects", 
          "subjects"
        ], 
        "name": "Reprogramming of human somatic cells to pluripotency with defined factors", 
        "pagination": "141-146", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1011992920"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nature06534"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "18157115"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nature06534", 
          "https://app.dimensions.ai/details/publication/pub.1011992920"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-09-02T15:51", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_434.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/nature06534"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nature06534'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nature06534'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nature06534'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nature06534'


     

    This table displays all metadata directly associated to this object as RDF triples.

    313 TRIPLES      21 PREDICATES      109 URIs      93 LITERALS      34 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nature06534 schema:about N1568571af9ad4c9b80b680f8dd4b8d35
    2 N1d27cc85e3bc4fff8ce0cf28a169dd50
    3 N2b4bb6ffa5884dcca7cb0b643f7b5601
    4 N38ffdd5a9892447daa5124998e4c5027
    5 N3cf00d29ee37427bb300874e989ebc58
    6 N4c354a375bc84a1591d738abc3ed938d
    7 N53bc5cc3b33f403490329f0d19d9a306
    8 N571f6012aefe4cec87ebe7bb67b22ca0
    9 N5b8c22205fea41a9937e9657bbf20b9f
    10 N70bf2f3482c0461f84bf8d5c2317350f
    11 N7202c5d5354846a18bda38de0ee1c367
    12 N734dcc3e39d84e4bafb2093ae5e1caf7
    13 N76804d189f3949adb4c097952395da8d
    14 N776a7ea5d47f41b6a91b0fe519de4d45
    15 N86300db65e284360bc7965268434f80e
    16 N978946589af3451ea75949f6997ddbd2
    17 N999c8c9680e34a70a084787c15958657
    18 N9cfa3a566bbb4adbaef18ecd435aeedd
    19 Na03d74da3027487a91e72c4b1e662535
    20 Na46b34551a684dac87d98f3fabcd2fdc
    21 Na4b1120a67204e969b91363c0ec708f4
    22 Naae9a04acc85432fb556c0fb096911e9
    23 Nb05ca454374a409e86dc9febc4c274bc
    24 Nb78a2a5e8b2f419f8e91291d6e40d135
    25 Ncc3d23d682894e20903ca872a3640ef4
    26 Ndccb20d46c804b9dac08407436dfc581
    27 Ne1e00f8dafbd4ae587f18d363feefa63
    28 anzsrc-for:06
    29 anzsrc-for:0604
    30 schema:author N0e5d40966d0e42c5808a3c4fea143b2c
    31 schema:citation sg:pub.10.1038/22780
    32 sg:pub.10.1038/nature05934
    33 sg:pub.10.1038/nature05944
    34 sg:pub.10.1038/nbt1107-1211a
    35 sg:pub.10.1038/nbt1310
    36 sg:pub.10.1038/nbt1318
    37 sg:pub.10.1038/nbt1335
    38 sg:pub.10.1038/nbt788
    39 schema:datePublished 2007-12-23
    40 schema:datePublishedReg 2007-12-23
    41 schema:description Pluripotency pertains to the cells of early embryos that can generate all of the tissues in the organism. Embryonic stem cells are embryo-derived cell lines that retain pluripotency and represent invaluable tools for research into the mechanisms of tissue formation. Recently, murine fibroblasts have been reprogrammed directly to pluripotency by ectopic expression of four transcription factors (Oct4, Sox2, Klf4 and Myc) to yield induced pluripotent stem (iPS) cells. Using these same factors, we have derived iPS cells from fetal, neonatal and adult human primary cells, including dermal fibroblasts isolated from a skin biopsy of a healthy research subject. Human iPS cells resemble embryonic stem cells in morphology and gene expression and in the capacity to form teratomas in immune-deficient mice. These data demonstrate that defined factors can reprogramme human cells to pluripotency, and establish a method whereby patient-specific cells might be established in culture.
    42 schema:genre article
    43 schema:isAccessibleForFree false
    44 schema:isPartOf N92f936e0afdd44bdb4dfe35c885f055b
    45 Nef8297a8ecf94117ab017b3c7fe4be40
    46 sg:journal.1018957
    47 schema:keywords biopsy
    48 capacity
    49 cell lines
    50 cells
    51 culture
    52 data
    53 defined factors
    54 dermal fibroblasts
    55 early embryos
    56 ectopic expression
    57 embryonic stem cells
    58 embryos
    59 expression
    60 factors
    61 fibroblasts
    62 formation
    63 gene expression
    64 healthy research subjects
    65 human cells
    66 human iPS cells
    67 human primary cells
    68 human somatic cells
    69 iPS cells
    70 immune-deficient mice
    71 induced pluripotent stem cells
    72 invaluable tool
    73 lines
    74 mechanism
    75 method
    76 mice
    77 morphology
    78 murine fibroblasts
    79 organisms
    80 patient-specific cells
    81 pluripotency
    82 pluripotent stem cells
    83 primary cells
    84 research
    85 research subjects
    86 same factors
    87 skin biopsies
    88 somatic cells
    89 stem cells
    90 subjects
    91 teratoma
    92 tissue
    93 tissue formation
    94 tool
    95 transcription factors
    96 schema:name Reprogramming of human somatic cells to pluripotency with defined factors
    97 schema:pagination 141-146
    98 schema:productId N0b4f5285e5e14557b77be857bc5e1b1a
    99 N3bb8094822614a32b74c80c7afb5b359
    100 N4550b64855f0404a84fa4bb18d545ec8
    101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011992920
    102 https://doi.org/10.1038/nature06534
    103 schema:sdDatePublished 2022-09-02T15:51
    104 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    105 schema:sdPublisher Neadc08661f7448599ea2e7be9ee25b5a
    106 schema:url https://doi.org/10.1038/nature06534
    107 sgo:license sg:explorer/license/
    108 sgo:sdDataset articles
    109 rdf:type schema:ScholarlyArticle
    110 N0b4f5285e5e14557b77be857bc5e1b1a schema:name dimensions_id
    111 schema:value pub.1011992920
    112 rdf:type schema:PropertyValue
    113 N0e5d40966d0e42c5808a3c4fea143b2c rdf:first sg:person.0633264666.40
    114 rdf:rest N860cf6e8fc6843d0835b1763dc83f1ad
    115 N1568571af9ad4c9b80b680f8dd4b8d35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Octamer Transcription Factor-3
    117 rdf:type schema:DefinedTerm
    118 N1d27cc85e3bc4fff8ce0cf28a169dd50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name Homeodomain Proteins
    120 rdf:type schema:DefinedTerm
    121 N2b4bb6ffa5884dcca7cb0b643f7b5601 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Promoter Regions, Genetic
    123 rdf:type schema:DefinedTerm
    124 N37ea4bb6687744b1b071450dd612a988 rdf:first sg:person.01206166374.49
    125 rdf:rest Nc9157c222e8047b683efdd2b3d694892
    126 N38ffdd5a9892447daa5124998e4c5027 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    127 schema:name Teratoma
    128 rdf:type schema:DefinedTerm
    129 N3bb8094822614a32b74c80c7afb5b359 schema:name doi
    130 schema:value 10.1038/nature06534
    131 rdf:type schema:PropertyValue
    132 N3cf00d29ee37427bb300874e989ebc58 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    133 schema:name Pluripotent Stem Cells
    134 rdf:type schema:DefinedTerm
    135 N4550b64855f0404a84fa4bb18d545ec8 schema:name pubmed_id
    136 schema:value 18157115
    137 rdf:type schema:PropertyValue
    138 N4c354a375bc84a1591d738abc3ed938d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name Nanog Homeobox Protein
    140 rdf:type schema:DefinedTerm
    141 N53bc5cc3b33f403490329f0d19d9a306 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name DNA-Binding Proteins
    143 rdf:type schema:DefinedTerm
    144 N571f6012aefe4cec87ebe7bb67b22ca0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Kruppel-Like Transcription Factors
    146 rdf:type schema:DefinedTerm
    147 N5b8c22205fea41a9937e9657bbf20b9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Fetus
    149 rdf:type schema:DefinedTerm
    150 N70bf2f3482c0461f84bf8d5c2317350f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Cell Shape
    152 rdf:type schema:DefinedTerm
    153 N7202c5d5354846a18bda38de0ee1c367 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Infant, Newborn
    155 rdf:type schema:DefinedTerm
    156 N734dcc3e39d84e4bafb2093ae5e1caf7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Cell Differentiation
    158 rdf:type schema:DefinedTerm
    159 N76804d189f3949adb4c097952395da8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Transcription Factors
    161 rdf:type schema:DefinedTerm
    162 N776a7ea5d47f41b6a91b0fe519de4d45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Embryonic Stem Cells
    164 rdf:type schema:DefinedTerm
    165 N860cf6e8fc6843d0835b1763dc83f1ad rdf:first sg:person.0701400066.39
    166 rdf:rest Nf785eb70602343efa92901710500b841
    167 N86300db65e284360bc7965268434f80e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    168 schema:name Gene Expression Profiling
    169 rdf:type schema:DefinedTerm
    170 N92f936e0afdd44bdb4dfe35c885f055b schema:volumeNumber 451
    171 rdf:type schema:PublicationVolume
    172 N978946589af3451ea75949f6997ddbd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Adult
    174 rdf:type schema:DefinedTerm
    175 N999c8c9680e34a70a084787c15958657 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Mice
    177 rdf:type schema:DefinedTerm
    178 N9cfa3a566bbb4adbaef18ecd435aeedd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    179 schema:name Cells, Cultured
    180 rdf:type schema:DefinedTerm
    181 Na03d74da3027487a91e72c4b1e662535 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name Proto-Oncogene Proteins c-myc
    183 rdf:type schema:DefinedTerm
    184 Na46b34551a684dac87d98f3fabcd2fdc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    185 schema:name Transplantation, Heterologous
    186 rdf:type schema:DefinedTerm
    187 Na4b1120a67204e969b91363c0ec708f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    188 schema:name DNA Methylation
    189 rdf:type schema:DefinedTerm
    190 Naae9a04acc85432fb556c0fb096911e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    191 schema:name Fibroblasts
    192 rdf:type schema:DefinedTerm
    193 Nb05ca454374a409e86dc9febc4c274bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    194 schema:name Animals
    195 rdf:type schema:DefinedTerm
    196 Nb2f8689a22874186b454993d78a6e07c rdf:first sg:person.01326207001.66
    197 rdf:rest rdf:nil
    198 Nb78a2a5e8b2f419f8e91291d6e40d135 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    199 schema:name Kruppel-Like Factor 4
    200 rdf:type schema:DefinedTerm
    201 Nbef864ae432d422fba0b3e69879a8f78 rdf:first sg:person.01071737774.79
    202 rdf:rest Ndb7b2958ab8f4dbeb2537765222643d3
    203 Nc9157c222e8047b683efdd2b3d694892 rdf:first sg:person.01233401714.29
    204 rdf:rest Nbef864ae432d422fba0b3e69879a8f78
    205 Ncc3d23d682894e20903ca872a3640ef4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    206 schema:name HMGB Proteins
    207 rdf:type schema:DefinedTerm
    208 Ndb7b2958ab8f4dbeb2537765222643d3 rdf:first sg:person.01022207136.99
    209 rdf:rest Nb2f8689a22874186b454993d78a6e07c
    210 Ndccb20d46c804b9dac08407436dfc581 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    211 schema:name Humans
    212 rdf:type schema:DefinedTerm
    213 Ne1e00f8dafbd4ae587f18d363feefa63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    214 schema:name SOXB1 Transcription Factors
    215 rdf:type schema:DefinedTerm
    216 Neadc08661f7448599ea2e7be9ee25b5a schema:name Springer Nature - SN SciGraph project
    217 rdf:type schema:Organization
    218 Nef8297a8ecf94117ab017b3c7fe4be40 schema:issueNumber 7175
    219 rdf:type schema:PublicationIssue
    220 Nf785eb70602343efa92901710500b841 rdf:first sg:person.01300040514.16
    221 rdf:rest Nf98359c5474d47abb921b3aa5a2e9341
    222 Nf98359c5474d47abb921b3aa5a2e9341 rdf:first sg:person.01165236266.47
    223 rdf:rest N37ea4bb6687744b1b071450dd612a988
    224 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    225 schema:name Biological Sciences
    226 rdf:type schema:DefinedTerm
    227 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
    228 schema:name Genetics
    229 rdf:type schema:DefinedTerm
    230 sg:journal.1018957 schema:issn 0028-0836
    231 1476-4687
    232 schema:name Nature
    233 schema:publisher Springer Nature
    234 rdf:type schema:Periodical
    235 sg:person.01022207136.99 schema:affiliation grid-institutes:grid.38142.3c
    236 schema:familyName Lensch
    237 schema:givenName M. William
    238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022207136.99
    239 rdf:type schema:Person
    240 sg:person.01071737774.79 schema:affiliation grid-institutes:grid.2515.3
    241 schema:familyName Lerou
    242 schema:givenName Paul H.
    243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071737774.79
    244 rdf:type schema:Person
    245 sg:person.01165236266.47 schema:affiliation grid-institutes:grid.38142.3c
    246 schema:familyName Yabuuchi
    247 schema:givenName Akiko
    248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165236266.47
    249 rdf:type schema:Person
    250 sg:person.01206166374.49 schema:affiliation grid-institutes:grid.38142.3c
    251 schema:familyName Huo
    252 schema:givenName Hongguang
    253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206166374.49
    254 rdf:type schema:Person
    255 sg:person.01233401714.29 schema:affiliation grid-institutes:grid.62560.37
    256 schema:familyName Ince
    257 schema:givenName Tan A.
    258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233401714.29
    259 rdf:type schema:Person
    260 sg:person.01300040514.16 schema:affiliation grid-institutes:grid.38142.3c
    261 schema:familyName West
    262 schema:givenName Jason A.
    263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300040514.16
    264 rdf:type schema:Person
    265 sg:person.01326207001.66 schema:affiliation grid-institutes:grid.38142.3c
    266 schema:familyName Daley
    267 schema:givenName George Q.
    268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326207001.66
    269 rdf:type schema:Person
    270 sg:person.0633264666.40 schema:affiliation grid-institutes:grid.38142.3c
    271 schema:familyName Park
    272 schema:givenName In-Hyun
    273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633264666.40
    274 rdf:type schema:Person
    275 sg:person.0701400066.39 schema:affiliation grid-institutes:grid.38142.3c
    276 schema:familyName Zhao
    277 schema:givenName Rui
    278 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701400066.39
    279 rdf:type schema:Person
    280 sg:pub.10.1038/22780 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021312708
    281 https://doi.org/10.1038/22780
    282 rdf:type schema:CreativeWork
    283 sg:pub.10.1038/nature05934 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002347899
    284 https://doi.org/10.1038/nature05934
    285 rdf:type schema:CreativeWork
    286 sg:pub.10.1038/nature05944 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019109862
    287 https://doi.org/10.1038/nature05944
    288 rdf:type schema:CreativeWork
    289 sg:pub.10.1038/nbt1107-1211a schema:sameAs https://app.dimensions.ai/details/publication/pub.1003688019
    290 https://doi.org/10.1038/nbt1107-1211a
    291 rdf:type schema:CreativeWork
    292 sg:pub.10.1038/nbt1310 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024578139
    293 https://doi.org/10.1038/nbt1310
    294 rdf:type schema:CreativeWork
    295 sg:pub.10.1038/nbt1318 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033397919
    296 https://doi.org/10.1038/nbt1318
    297 rdf:type schema:CreativeWork
    298 sg:pub.10.1038/nbt1335 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049953935
    299 https://doi.org/10.1038/nbt1335
    300 rdf:type schema:CreativeWork
    301 sg:pub.10.1038/nbt788 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013128911
    302 https://doi.org/10.1038/nbt788
    303 rdf:type schema:CreativeWork
    304 grid-institutes:grid.2515.3 schema:alternateName Division of Newborn Medicine, Brigham & Women’s Hospital and Children’s Hospital Boston, Boston, Massachusetts 02115, USA
    305 schema:name Division of Newborn Medicine, Brigham & Women’s Hospital and Children’s Hospital Boston, Boston, Massachusetts 02115, USA
    306 rdf:type schema:Organization
    307 grid-institutes:grid.38142.3c schema:alternateName Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School
    308 schema:name Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School
    309 Division of Pediatric Hematology/Oncology, Children’s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women’s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA
    310 rdf:type schema:Organization
    311 grid-institutes:grid.62560.37 schema:alternateName Department of Pathology, Brigham and Women’s Hospital, and
    312 schema:name Department of Pathology, Brigham and Women’s Hospital, and
    313 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...